Sunshine Biopharma (SBFM) Shares Outstanding (Diluted) (2021 - 2026)
Powered by 
Analysis
Sunshine Biopharma (SBFM) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn | 1.17 Bn |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | 1.16 Bn |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 833.33 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 328.10 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 518.87 Mn | 2.10 Bn | 378.10 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 291.34 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 21.92 Mn |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn | 44.23 Mn |
| 9 | Fennec Pharmaceuticals | 405.56 Mn | 364.31 Mn | 17.15 Mn | 36.43 Mn |
| 10 | Sunshine Biopharma | 1.56 Mn | -12.19 Mn | 2.43 Mn | 392,524.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 392,524.00 |
| Mar 31, 2026 | 392,524.00 |
| Dec 31, 2025 | 392,524.00 |
| Sep 30, 2025 | 392,524.00 |
| Jun 30, 2025 | 360,465.00 |
| Mar 31, 2025 | 270,329.00 |
| Dec 31, 2024 | 70,175.00 |
| Sep 30, 2024 | 126,756.00 |
| Jun 30, 2024 | 4,973.00 |
| Mar 31, 2024 | 3,207.00 |
| Dec 31, 2023 | 121,660.00 |
| Sep 30, 2023 | 128,452.00 |
| Jun 30, 2023 | 126,751.00 |
| Mar 31, 2023 | 110,181.00 |
| Dec 31, 2022 | 75,904.00 |
| Sep 30, 2022 | 94,428.00 |
| Jun 30, 2022 | 79,248.00 |
| Mar 31, 2022 | 26,364.00 |
| Dec 31, 2021 | 13,060.00 |